J0584 Injection, burosumab-twza 1m
J-Codes
Also known as: burosumab-twza, Crysvita
Burosumab-twza injection, 1 milligram, a monoclonal antibody against fibroblast growth factor 23 (FGF23) for X-linked hypophosphatemia treatment.
Clinical Context
First-in-class FGF23 antagonist indicated for X-linked hypophosphatemia, a hereditary disorder causing severe hypophosphatemia and rickets. Corrects phosphate reabsorption by inhibiting FGF23 signaling.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.